3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
8
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Perioperative Inflammatory Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurotoxicity Syndromes
1
Interventions
Oxaliplatin
3
Irinotecan
3
Fluorouracil
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Colonoscopy
2
Bisacodyl
2
Aspirin
2
lutetium Lu 177 dotatate
1
guadecitabine
1
copper dotatate CU-64
1
camrelizumab
1
apatinib
1
aldesleukin
1
XELOX
1
Ursodeoxycholic Acid
1
Trastuzumab
1
Suction
1
Simvastatin
1
Radiotherapy
1
Polyethylene Glycols
1
Oviposition
1
Lutetium-177
1
Lutetium
1
Ileostomy
1
Folfox protocol
1
Drainage
1
Cyclophosphamide
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Intestinal Neoplasms
×
Simvastatin
×
Clear all
NCT00994903
2013-12-02
StatCol
University of Auckland, New Zealand
Phase 3
Completed
132 enrolled